Purpose
The purpose was to 1) determine whether standard clinical muscle fatty infiltration and atrophy assessment techniques using a single image slice for patients with a rotator cuff tear (RCT) are correlated with three-dimensional measures in older individuals (60+ years), and 2) determine whether age-associated changes to muscle morphology and strength are compounded by a RCT.
Methods
Twenty older subjects were studied, 10 with a RCT of the supraspinatus (5M/5F) and 10 matched controls. Clinical imaging assessments (Goutallier, Fuchs scores; cross-sectional area ratio) were made for RCT subjects. Three-dimensional measurements of rotator cuff muscle and fat tissues were made for all subjects using MRI. Isometric joint moment was measured at the shoulder.
Results
There were no significant associations between single-image assessments and three-dimensional measurements of fatty infiltration for supraspinatus and infraspinatus. Compared to controls, RCT subjects had significantly increased fatty infiltration percentages for each rotator cuff muscle (all p≤0.023), reduced whole muscle volume for supraspinatus, infraspinatus, and subscapularis (all p≤0.038), and reduced fat-free muscle volume for supraspinatus, infraspinatus, and subscapularis (all p≤0.027). Only teres minor (p=0.017) fatty infiltration volume was significantly greater for RCT subjects. Adduction, flexion, and external rotation strength (all p≤0.021) were significantly reduced for RCT subjects, and muscle volume was a significant predictor of strength for all comparisons.
Conclusions
Clinical scores using a single image slice do not represent three-dimensional muscle measurements. Efficient methods are needed to more effectively capture three-dimensional information for clinical applications. RCT subjects had increased fatty infiltration percentages likely driven by muscle atrophy rather than increased fat volume. Muscle volume’s significant association with strength production suggests that treatments to preserve muscle volume should be pursued for older RCT patients.
Level of Evidence
Level II, diagnostic study, with development of diagnostic criteria on the basis of consecutive patients with universally applied reference “gold” standard.